Is this you?
Request access for Austin Heart with your @austinheart.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Intera lens
ICP 6Lift (cardio sample) 0.55Recruit soph 0.29
Quality Scorecard (1–100)
Overall81Recruit76Ops84Sponsor85Ther81
Performance (observed)
Historical trials
346
Completed
200
Terminated/Withdrawn
29
Completion rate
87%
Active now
106
Phase 2
48
Phase 3
155
Realized enrollment
4,216,885
First study year
1988
Years active
38
Match confidence
high
Enrollment velocity (inf)
110,971
Therapeutic
Areas
Cardiology, Interventional Cardiology, Congestive Heart Failure, Coronary/Peripheral Interventions
Specialties
Cardiology/Cardiac research
Breadth (conditions)
418
States
Texas
Recruitment (web observed)
Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Unknown (website geo-restricted)
Capability notes
High - Since 1995, extensive research infrastructure
Relationships
Sponsors
Abbott Medical Devices; Children's Oncology Group; Pfizer; Boston Scientific Corporation; National Cancer Institute (NCI); Novo Nordisk A/S
CROs
ICON Clinical Research; IQVIA Biotech; IQVIA Pvt. Ltd; Syneos Health
Owner / parent
St. David's HealthCare (HCA Healthcare affiliated)
Capacity & people
Investigators
—
Coordinators
—
CEO
Unknown
VP Clinical Ops
Unknown
VP Site Ops
Unknown
VP Recruitment
Dr. Kunjan Bhatt, MD (Research Department Medical Director)
Emails
Mary.Fraser@hcahealthcare.com
Tech & DCT
eConsent
Yes
Builds tech
Unknown
DCT / decentralized
Y (site mentions)
Tech stack
Advanced cardiology research equipment and protocols
Recruiting visible
Y
Notes
ClinicalTrials.gov validation: 7 active recruiting cardiometabolic trials. Research program operating since 1995 with Phase I-IV expertise. Strong Principal Investigator team (30+ studies led by Dr. Zidar). Located in Austin cardiac research hub.
Recommendation features (sample indication)
Ind fit 0.78Liftability 0.55Overall81
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.